Suscribirse

Photon-counting CT-derived extracellular volume in acute myocarditis: Comparison with cardiac MRI - 02/07/25

Doi : 10.1016/j.diii.2025.03.001 
Christos Gkizas a, , Benjamin Longere a, b, Olga Sliwicka a, Aimee Rodriguez Musso a, Gilles Lemesle b, c, Cedric Croisille d, Mehdi Haidar a, Francois Pontana a, b
a Department of Cardiovascular Imaging, Heart and Lung Institute, University Hospital of Lille, 59000 Lille, France 
b INSERM UMR 1011, Institute Pasteur of Lille, EGID (European Genomic Institute for Diabetes), FR3508; Univ Lille, 59000, Lille, France 
c Cardiac Intensive Care Unit and Hemodynamic Center, Heart and Lung Institute, University Hospital of Lille, 59000, Lille, France 
d Siemens Healthineers, 33600, Bordeaux, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Extracellular volume calculation using iodine maps from late enhancement by cardiac dual-source photon-counting detector computed tomography is feasible.
Excellent correlation is found between photon-counting detector computed tomography and magnetic resonance imaging for the estimation of extracellular volume in patients with myocarditis.
A two-acquisition protocol with a 5-minute delay late enhancement acquisition could accurately assess myocarditis.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

The purpose of this study was to evaluate the feasibility and the accuracy of myocardial late iodine enhancement for extracellular volume (ECV) quantification using dual-source photon-counting detector computed tomography (PCD-CT) in patients with suspected acute myocarditis by comparison with cardiac MRI.

Materials and methods

Patients with clinical suspicion of myocarditis who were referred for coronary CT angiography (CCTA) to exclude coronary artery disease were included in this retrospective study. All patients underwent CCTA examination using a first-generation PCD-CT, which included slate iodine enhancement images. ECV was calculated from the iodine ratio of the myocardium to the blood pool on late iodine enhancement PCD-CT images. A comprehensive cardiac MRI protocol was used as the reference method to confirm myocarditis according to the Lake Louise 2018 criteria. All subjects underwent CCTA using PCD-CT and cardiac MRI within 24 h. The mean dose-length product of late enhancement PCD-CT scanning was calculated. Correlations between ECV PCD-CT (endocardial, epicardial, midcardial, and global), cardiac MRI-LGE, and right and left ventricular ejection fractions were assessed using Pearson correlation test. ECV values derived from PCD-CT and those from cardiac MRI were compared using Bland Altman plots and linear regression analysis. Areas under the receiver operating characteristic curves (AUCs) were used to determine the optimal thresholds of ECV-PCD-CT and ECV-MRI for differentiating patients with myocarditis from those not meeting the Lake Louise criteria.

Results

Thirty-two patients were included. There were 19 men and 13 women with a mean age of 35.9 ± 15.0 (standard deviation [SD]) years; age range: 21–51). The mean dose-length product of late enhancement PCD-CT scanning was 96 ± 32 (SD) mGy.cm. No significant differences in mean global ECV were found between ECV calculated with the PCD-CT (29.4 ± 4.5 [SD] %) and that calculated with cardiac MRI (30.0 ± 4.1 [SD] %) ( P = 0.69). ECV-CT was greater in patients with cardiac MRI-confirmed myocarditis (31.65 ± 3.6 [SD] %) by comparison with those with normal findings (25.6 ± 3.2 [SD] %) ( P   <  0.01). ECV-CT strongly correlated with LGE mass ( r  = 0.82) and showed strong segmental correlation with ECV-MRI (basal: r  = 0.95; mid-ventricular: r = 0.91). An ECV-CT threshold of 26.9 % yielded an AUC of 0.95 (95 % CI: 0.84–1.00) for the diagnosis of myocarditis.

Conclusion

Calculation of ECV using iodine maps derived from late iodine enhancement cardiac PCD-CT images is both feasible and accurate at low radiation doses. PCD-CT appears as a promising non-invasive imaging modality for the diagnostic and prognostic assessment of acute myocarditis in the setting of chest pain.

El texto completo de este artículo está disponible en PDF.

Keywords : Coronary artery disease, Computed tomography, Dual-source photon counting, Extracellular volume, Myocarditis

Abbreviation : AUC, DLP, CAD, CAD-RADS, CT, CCTA, ECG, ECV, EF, ICC, LGE, LIE, LV, LVEF, MRI, PCD, PPV, SD


Esquema


© 2025  Société française de radiologie. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 106 - N° 7-8

P. 255-263 - juillet 2025 Regresar al número
Artículo precedente Artículo precedente
  • Cardiac magnetic resonance imaging in the follow-up of patients with Fabry cardiomyopathy
  • Jules Senlis, Fabien Labombarda, Julien Burel, Arthur Flouriot, Sébastien Normant, Matthieu Demeyere, Olivier Lairez, Soraya El Ghannudi, Alexis Jacquier, Olivier Ghekiere, Farah Cadour, Jean-Nicolas Dacher
| Artículo siguiente Artículo siguiente
  • Generative T2*-weighted images as a substitute for true T2*-weighted images on brain MRI in patients with acute stroke
  • Antoine Pelcat, Alice Le Berre, Wagih Ben Hassen, Clement Debacker, Sylvain Charron, Bertrand Thirion, Laurence Legrand, Guillaume Turc, Catherine Oppenheim, Joseph Benzakoun

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2026 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.